EthonAI secures CHF 15m to advance its AI-driven Manufacturing Analytics System, enhancing factory efficiency and reducing waste.

Galenica sees robust sales growth across all sectors, driven by strong pharmaceutical market.

Swiss tech industry struggles with declining sales and exports, but stabilization signs offer hope for recovery in 2024.

Swixx BioPharma significantly expands its market reach in Latin America by acquiring Biopas, enhancing its presence in neurology, oncology, and other therapeutic areas.

More and more truants, high salaries for health insurance company bosses and the energy transition is becoming more expensive than expected: this and more can be found in the Sunday newspapers.

Swiss cleantech leader Bcomp announces a significant Series C funding round. Bcomp Management + Company Website Swiss-based Bcomp, a pioneer in lightweight composite solutions, has successfully raised $40 million in a Series C funding round, demonstrating confidence in its mission to enhance mobility decarbonisation.

Switzerland becomes the 37th nation to sign the Artemis Accords at NASA Headquarters.

German firm Diehl Defence partners with Swiss company Skysec Defence to develop advanced drone defence systems.

Vantage Data Centers invests over CHF 370 million in a second Zurich campus, ZRH2, enhancing the EMEA region's computing power.

Addex and Perceptive Advisors unveil Neurosterix, backed by a hefty $63 million investment, to revolutionise treatment for neurological disorders.

Geneva-based ObsEva, dedicated to pioneering women's reproductive health solutions, announces its upcoming delisting from the SIX Swiss Exchange.

Terra Quantum AG forges a landmark partnership with MegazoneCloud, setting a course for quantum innovation in Asia.

Amidst a period of significant transitions, Lonza secures Wolfgang Wienand for its top executive role.

Hive's innovative approach turns idle device capacity into a global supercomputer, securing €12M from SC Ventures to make sustainable cloud computing accessible to all.

Ypsomed transitions pen needle and BGM business to MTD, channeling investment into expanding Solothurn site and enhancing insulin pump solutions.

Volumina Medical's USD 21 million Series A success spells a new dawn for tissue regeneration.

Hemotune's innovative blood purification platform, HemoSystem, propels into clinical trials with a CHF 14 million Series B2 boost.

Salt secures a substantial customer base increase and a robust rise in EBITDA. Keystone/JEAN-CHRISTOPHE BOTT Salt grew last year and increased its operating profit.